- and in
general can be
avoided with the use of
synthetic heparins. Not all
patients with
heparin antibodies will
develop thrombocytopenia. Also, a benign...
- (December 2007). "Intravenous low-molecular-weight
heparins compared with
unfractionated heparin in
percutaneous coronary intervention: quantitative...
- low-molecular-weight
heparin (LMWH) or
unfractionated heparin, or
increasingly with
direct acting oral
anticoagulants (DOAC).
Those initially treated with
heparins can...
- is
generally given subcutaneously.
Commonly used low
molecular weight heparins are enoxaparin, dalteparin,
nadroparin and tinzaparin. In HIT, the platelet...
- is an
antithrombotic and
belongs to the
group of low
molecular weight heparins (LMWH).
Bemiparin is used for the
prevention of
thromboembolism after surgery...
- A 2021
review found that low
molecular weight heparin (LMWH) was
superior to
unfractionated heparin in the
initial treatment of
venous thromboembolism...
-
Several anticoagulants are available. Warfarin,
other coumarins, and
heparins have long been used.
Since the 2000s,
several agents have been introduced...
- medication. It is a low
molecular weight heparin,
primarily active against factor Xa. Like
other low
molecular weight heparins, it is used to
prevent deep venous...
-
Dalteparin is a low
molecular weight heparin. It is
marketed as Fragmin. Like
other low
molecular weight heparins,
dalteparin is used for
prophylaxis or...
-
uncoated CPB
circuits require a high dose of
systemic heparin.
Although the
effects of
heparin are
reversible by
administering protamine,
there are a...
